Summit Therapeutics  

Miami,  FL 
United States
https://www.smmttx.com
  • Booth: 14039

 Products

  • Ivonescimab
    Ivonescimab is an investigational, novel, potential first-in-class bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays cooperative binding to each of its intended targets with higher affinity when in the presence of both PD-1 and VEGF.
     ...

Categories

Cancer Types
  • Lung Cancer
    • Categories:
  • Biotechnology
  • Clinical Trials
  • Immunotherapy
  • Pharmaceutical
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined